Literature DB >> 19168470

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.

R Minhas1, S E Humphries, N Qureshi, H A W Neil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19168470     DOI： 10.1136/hrt.2008.162909

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  11 in total

1.  Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?

Authors:  Wolf H Rogowski; Scott D Grosse; Jörg Schmidtke; Georg Marckmann
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

2.  Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.

Authors:  Ingrid Brænne; Mariana Kleinecke; Benedikt Reiz; Elisabeth Graf; Tim Strom; Thomas Wieland; Marcus Fischer; Thorsten Kessler; Christian Hengstenberg; Thomas Meitinger; Jeanette Erdmann; Heribert Schunkert
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

3.  Changing the conversation regarding pediatric cholesterol screening: the rare disease paradigm.

Authors:  Matthew W Gillman
Journal:  Arch Pediatr Adolesc Med       Date:  2012-12

4.  An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations.

Authors:  Maria Romano; Maria Donata Di Taranto; Peppino Mirabelli; Maria Nicoletta D'Agostino; Arcangelo Iannuzzi; Gennaro Marotta; Marco Gentile; Maddalena Raia; Rosa Di Noto; Luigi Del Vecchio; Paolo Rubba; Giuliana Fortunato
Journal:  J Lipid Res       Date:  2011-08-24       Impact factor: 5.922

Review 5.  Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

Authors:  Michael J Sorich; Michael D Wiese; Rebekah L O'Shea; Brita Pekarsky
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

Review 6.  Screening strategies for cardiovascular disease in asymptomatic adults.

Authors:  Margaret L Wallace; Jason A Ricco; Bruce Barrett
Journal:  Prim Care       Date:  2014-03-27       Impact factor: 2.907

7.  Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.

Authors:  Ingrid Brænne; Benedikt Reiz; Anja Medack; Mariana Kleinecke; Marcus Fischer; Salih Tuna; Christian Hengstenberg; Panos Deloukas; Jeanette Erdmann; Heribert Schunkert
Journal:  BMC Cardiovasc Disord       Date:  2014-08-26       Impact factor: 2.298

Review 8.  Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland.

Authors:  Andrzej Pajak; Krystyna Szafraniec; Maciej Polak; Wojciech Drygas; Walerian Piotrowski; Tomasz Zdrojewski; Piotr Jankowski
Journal:  Arch Med Sci       Date:  2016-05-05       Impact factor: 3.318

9.  Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States.

Authors:  Shravanthi R Gandra; Guillermo Villa; Gregg C Fonarow; Mickael Lothgren; Peter Lindgren; Ransi Somaratne; Ben van Hout
Journal:  Clin Cardiol       Date:  2016-04-19       Impact factor: 2.882

10.  Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.

Authors:  C S Paththinige; J R D K Rajapakse; G R Constantine; K P Sem; R R Singaraja; R W Jayasekara; V H W Dissanayake
Journal:  Lipids Health Dis       Date:  2018-05-02       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.